We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TVM Life Science Ventures VII Announces First Investment

News   Jan 22, 2013

 
TVM Life Science Ventures VII Announces First Investment
 
 
 

RELATED ARTICLES

Discontinuing Oral Immunotherapy for Peanut Allergy Reduces Its Protective Effects

News

A study has followed participants after oral immunotherapy (OIT) for peanut allergy have found that discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects.

READ MORE

Diabetes Drug Promotes Brain Repair – But It Only Works in Females

News

A new study by U of T scientists shows that a female sex hormone plays a key role in promoting brain repair and opens the door to the development of more effective treatments.

READ MORE

New Biological Targets Could Help Devise Alternative Cancer Therapies

News

A team of geneticists has discovered new biological targets that may help devise alternative cancer therapies that are becoming resistant to existing drugs.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE